Canada · Health Canada Drug Product Database
MIDAZOLAM INJECTION BP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65417
- DIN
- 02241754
- Form
- Solution
- Company as listed by source
- HOSPIRA HEALTHCARE ULC
- Source status
- Cancelled Pre Market (2018-09-05)
- Source last updated
- 2025-03-22
Source-listed ingredients
- MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) — 5 MG — per 1 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 1ml/2ml/10ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →